Abstergo Industries is excited to announce the upcoming release of the latest version of the a-OS, our proprietary operating system for the Animus. The new a-OS, known as a-OS 23, represents a major upgrade from previous versions and includes a number of exciting new features. One of the key improvements of a-OS 23 is its […]
Abstergo Industries is proud to announce the latest iteration of the Animus, the revolutionary device that allows our researchers to experience the genetic memories of our test subject’s ancestors. The Animus has been a key tool in our research into the field of genetic memory, and the new Animus represents a major step forward in […]
Over the past two years, we have made significant progress in a number of key areas and wanted to take a moment to update you on our recent activities. As a global leader in the pharmaceutical, finance, and technology sectors, it is our responsibility to stay attuned to global developments and adapt accordingly. In light […]
Abstergo Pharmaceuticals was one of the first companies to conduct research on an active pharmaceutical substance against COVID-19. Since December 2019, we have made enormous progress. After the first tests on chimpanzees were successful in June, a test study on a small number of sick people was started in July. After this test was also […]
Together with the new Animus-OS, a video game will be released that reproduces content from real Animus sessions in playable form. By analyzing the genetic memories of test subjects of the Animus we were able to achieve a high level of interactivity. This is characterized, for example, by a Norwegian village that you can expand, […]
Abstergo 